Evidence map›Paper›PMID 35625824›Full record

ReviewBiomedicines2022

Aryl Hydrocarbon Receptors: Evidence of Therapeutic Targets in Chronic Inflammatory Skin Diseases.

Han-Bi Kim, Ji-Young Um, Bo-Young Chung, Jin-Cheol Kim, Seok-Young Kang, Chun-Wook Park, Hye-One Kim

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Han-Bi KimDepartment of Dermatology, College of Medicine, Hallym University, Kangnam Sacred Heart Hospital, Seoul 150-950, Korea.
Ji-Young UmDepartment of Dermatology, College of Medicine, Hallym University, Kangnam Sacred Heart Hospital, Seoul 150-950, Korea.ORCID 0000-0003-2044-199X
Bo-Young ChungDepartment of Dermatology, College of Medicine, Hallym University, Kangnam Sacred Heart Hospital, Seoul 150-950, Korea.ORCID 0000-0002-2795-0140
Jin-Cheol KimDepartment of Dermatology, College of Medicine, Hallym University, Kangnam Sacred Heart Hospital, Seoul 150-950, Korea.ORCID 0000-0002-1523-6951
Seok-Young KangDepartment of Dermatology, College of Medicine, Hallym University, Kangnam Sacred Heart Hospital, Seoul 150-950, Korea.ORCID 0000-0001-6532-2244
Chun-Wook ParkDepartment of Dermatology, College of Medicine, Hallym University, Kangnam Sacred Heart Hospital, Seoul 150-950, Korea.ORCID 0000-0003-4512-8668
Hye-One KimDepartment of Dermatology, College of Medicine, Hallym University, Kangnam Sacred Heart Hospital, Seoul 150-950, Korea.ORCID 0000-0001-5846-0008
Hallym University Kangnam Sacred Heart Hospital · KR

Funding

Hallym University Research Fund HURF-2021-07Korea Centers for Disease Control and Prevention KCDC 2020-ER6714-00National Research Foundation of Korea NRF-2017R1A2B4006252
6 · The paper itself

Abstract

The aryl hydrocarbon receptor (AhR), a ligand-dependent transcription factor, is important for xenobiotic metabolism and binds to various endogenous and exogenous ligands present in the skin. AhR is known to be associated with diseases in various organs; however, its functions in chronic inflammatory skin diseases, such as atopic dermatitis (AD) and psoriasis (PS), have recently been elucidated. Here, we discuss the molecular mechanisms of AhR related to chronic inflammatory skin diseases, such as AD and PS, and the mechanisms of action of AhR on the skin immune system. The importance of AhR molecular biological pathways, clinical features in animal models, and AhR ligands in skin diseases need to be investigated. In conclusion, the therapeutic effects of AhR ligands are demonstrated based on the relationship between AhR and skin diseases. Nevertheless, further studies are required to elucidate the detailed roles of AhR in chronic inflammatory skin diseases.

Indexed as

2,3,7,8-tetrachlorodibenzo-p-dioxinaryl hydrocarbon receptorCYP1A1psoriasisTCDD

Identifiers

PMID35625824
PMCPMC9139118
OpenAlexW4229332392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.